✦ LIBER ✦

Recombinant interferon alfa-2a in cryptogenic chronic active liver disease

✍ Scribed by Diodati, C.; Bonetti, P.; Scaccabarozzi, S.; Tagger, A.; Realdi, G.; Alberti, A.; Ruol, A.

Book ID: 123536754
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 103 KB
Volume: 11
Category: Article
ISSN: 0168-8278
DOI: 10.1016/0168-8278(90)91669-N

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized controlled clinical trial o

A randomized controlled clinical trial of recombinant human alpha-2a interferon (IFN) in cryptogenic chronic active liver disease: Preliminary results

✍ Diodati, C.; Bonetti, P.; Maladorno, D.; Alberti, A.; Realdi, G.; Ruol, A. 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Recombinant interferon alfa-2a, an activ

Recombinant interferon alfa-2a, an active agent in advanced cutaneous t-cell lymphomas

✍ P. A. Bunn Jr.; D. C. Ihde; K. A. Foon 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 452 KB

The cutaneous T-cell lymphomas including mycosis fungoides and the Sézary syndrome, are indolent lymphomas with early systemic dissemination. Like the indolent B-cell lymphomas, they cannot be cured by currently available systemic chemotherapy so new systemic therapies need to be developed. A study

Mycophenolate mofetil in combination wit

Mycophenolate mofetil in combination with recombinant interferon alfa-2a in interferon-nonresponder patients with chronic hepatitis C

✍ Markus Cornberg; Holger Hinrichsen; Gerlinde Teuber; Thomas Berg; Uta Naumann; C 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Interferon related neuropsychiatric mani

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Recombinant human interferon alfa-2a in

Recombinant human interferon alfa-2a in community-acquired non-A, non-B chronic active hepatitis. Preliminary results of a randomized, controlled trial

✍ Realdi, G.; Diodati, G.; Bonetti, P.; Scaccabarozzi, S.; Alberti, A.; Ruol, A. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 246 KB

Interferon in HBV+ chronic active liver

Interferon in HBV+ chronic active liver disease: Low or high doses?

✍ Cimino, L.; Mattera, D.; Ambrogio, G.; Russo, T.; Citarella, C.; Cristodoro, C.; 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 63 KB